7 hedge funds and large institutions have $50M invested in BiomX in 2019 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 12 closing their positions.

Holders
7
Holders Change
-6
Holders Change %
-46.15%
% of All Funds
0.14%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
6
Increased
Reduced
1
Closed
12
Calls
$77K
Puts
Net Calls
+$77K
Net Calls Change
+$77K
Name Market Value Shares Shares
Change
Shares
Change %
O
1
OrbiMed
New York
$22.4M 2,313,489 +2,313,489 New
JJIJ
2
Johnson & Johnson Innovation - JJDC
New Jersey
$20.7M 2,133,402 +2,133,402 New
RI
3
RTW Investments
New York
$5.81M 600,000 +600,000 New
TWMP
4
Taylor Wealth Management Partners
Massachusetts
$489K 50,518 +50,518 New
ECM
5
ExodusPoint Capital Management
New York
$232K 23,978 +23,978 New
CC
6
Centiva Capital
New York
$200K 20,609 +20,609 New
KPF
7
K2 Principal Fund
Ontario, Canada
$161K 16,608 -368,838 -96%
PC
8
Periscope Capital
Ontario, Canada
-262,500 Closed
WAM
9
Weiss Asset Management
Massachusetts
-249,000 Closed
Walleye Trading
10
Walleye Trading
New York
-159,994 Closed
6CM
11
683 Capital Management
New York
-136,995 Closed
BCM
12
BlueCrest Capital Management
Jersey
-112,867 Closed
Walleye Capital
13
Walleye Capital
New York
-110,000 Closed
PAMP
14
Polar Asset Management Partners
Ontario, Canada
-105,825 Closed
PAM
15
Panagora Asset Management
Massachusetts
-100,141 Closed
NCM
16
Nantahala Capital Management
Connecticut
-100,000 Closed
BCM
17
Basso Capital Management
Connecticut
-94,799 Closed
GCL
18
Glazer Capital LLC
New York
-46,236 Closed
RCM
19
Rivernorth Capital Management
Florida
-30,000 Closed
CFGS
20
Concourse Financial Group Securities
Alabama
JGC
21
J. Goldman & Co
New York